Xgeva, whose chemical name is denosumab, is approved for use in those suffering from advanced prostate cancer which has moved into the patient’s bones. The drug is approved to help prevent fractures in these patients. It is administered by injection. The drug is manufactured by Amgen, Inc. Sales of Xgeva have skyrocketed in recent months…. Read More
Heparin Safety Recommendations – Four Years Later
In yet another example of the inadequacy of federal regulators to protect patient health, the FDA this month issued recommendations for measures to ensure that Heparin, the popular blood-clot prevention drug, was produced safely. While our products liability attorneys applaud the issuance of such recommendations, it is important to note that the agency has finally… Read More
Avastin Breast Cancer Approval Withdrawn
This week, the federal Food and Drug Administration announced its withdrawal of approval for Avastin, a commonly-used breast cancer drug. Avastin, the trade name for the drug bevacizumab, is one of a class of drugs known as “biological therapy.” The drug is a product of Genentech, a biotechnology company based in San Francisco, California. Avastin… Read More
Deceptive Marketing of Statins, Cholesterol Drugs
Our Chicago medical malpractice attorneys are, unfortunately, not shocked to learn that yet another class of drugs has been over-marketed and over-prescribed, to the financial benefit of the pharmaceutical companies and the harm of patients and the general public. This time it is statins that we have learned have been unnecessarily prescribed to millions of… Read More
Pharmaceutical Product Liability Has Disproportionate Effect on Women
The FDA, while a useful regulatory body in many ways, has now been proven unable to reign in the profit-hungry pharmaceutical industry. Whether through the lack of resources or the lack of motivation – or both – the FDA has utterly failed to protect patients from dangerous drugs and devices. The Chicago personal injury lawyers… Read More